plpp7 Antibody

What is PLPP7 and what are its alternative designations in scientific literature?

PLPP7 (Phospholipid Phosphatase 7) is a nuclear envelope transmembrane protein (NET) involved in genome organization and nuclear-cytoskeletal coupling. In scientific literature, PLPP7 may be referenced using various designations:

PLPP7 is a member of the PAP2 superfamily of phosphatases and haloperoxidases, initially discovered in an in silico screen for secreted or membrane proteins .

What are the typical applications for PLPP7 antibodies in research?

PLPP7 antibodies are versatile research tools that can be employed in multiple experimental approaches:

When designing experiments, researchers should consider that PLPP7 is primarily localized to the nuclear envelope as confirmed by subcellular localization studies .

Why does PLPP7 show discrepancy between calculated and observed molecular weights?

A noteworthy methodological consideration is the significant discrepancy between PLPP7's calculated and observed molecular weights:

• Calculated molecular weight: 29.4 kDa

• Observed molecular weight on Western blots: approximately 68 kDa

This discrepancy likely results from post-translational modifications, protein-protein interactions that resist denaturation, or the structural properties of this transmembrane protein. When validating PLPP7 antibodies via Western blot, researchers should expect to observe bands at approximately 68 kDa rather than at the calculated weight, and should use appropriate positive controls to confirm specificity.

How is PLPP7 expression altered in myotonic dystrophy type 1, and what methodologies best detect these changes?

PLPP7 expression shows significant alterations in myotonic dystrophy type 1 (DM1), a multisystemic disorder affecting primarily muscle and neurological tissues. Research has demonstrated:

• PLPP7 gene expression positively correlates with dorsiflexion strength in DM1 patients

• The main isoform (271 aa) is downregulated in DM1 muscle biopsies

• This downregulation has been confirmed at the protein level by Western blot in unrelated DM1 muscle biopsies

For reliable quantification of these expression changes, researchers should:

• Use Western blotting with normalization to housekeeping proteins (e.g., GAPDH)

• Employ the Licor FC imaging system and ImageStudio Software for quantification

• Perform at least three biological replicates to confirm results

• Consider correlation analyses between protein levels and clinical parameters (e.g., muscle strength)

What is the role of PLPP7 in genome organization, and how can researchers study PLPP7-regulated genes?

PLPP7 functions as a muscle-specific NET involved in genome organization. Research methodologies to study its impact on gene regulation include:

• RNA-sequencing analysis of tissues/cells with altered PLPP7 expression

• Comparison of differentially expressed genes with known PLPP7-regulated genes

In DM1 muscle biopsies, genes regulated by PLPP7 (and TMEM38A) represent:

• 13% of differentially expressed genes in proto-DM1

• 11% of differentially expressed genes in DM1

• 10% of differentially expressed genes in severe DM1

Pathway analysis of these PLPP7-regulated genes reveals enrichment in:

These findings indicate PLPP7's significant role in maintaining normal muscle gene expression patterns.

What experimental considerations are important when distinguishing between PLPP7 isoforms?

When investigating specific PLPP7 isoforms:

• The main isoform is 271 amino acids in length and shows the most significant downregulation in muscle disorders

• Researchers should select antibodies that can distinguish between isoforms if studying isoform-specific effects

• RNA-sequencing analysis can provide isoform-level expression data

• For protein level analysis, use Western blotting with high-resolution gels (10-15% TGX gels) capable of separating similar-sized isoforms

How can researchers effectively validate PLPP7 antibody specificity?

Thorough validation of PLPP7 antibodies is essential for reliable results:

• Multiple application testing: Validate the antibody in multiple applications (WB, IF, IHC) to ensure consistent results across platforms

• Cross-reactivity assessment: Test the antibody against related proteins, particularly other phospholipid phosphatases

• Knockdown/knockout controls: Use PLPP7-depleted samples as negative controls

• Peptide competition assays: Pre-incubate the antibody with immunizing peptide to confirm specificity

• Multiple antibody comparison: Use antibodies from different sources targeting different epitopes

Several commercial antibodies have undergone validation in multiple applications and species, with the most extensively validated including Proteintech Group (20635-1-AP) with 3 references and validation in WB, ELISA, and IP applications .

What is the relationship between PLPP7 and other nuclear envelope proteins in muscle pathology?

The relationship between PLPP7 and other nuclear envelope proteins offers important insights into muscle pathology:

• PLPP7 functions alongside other NETs like TMEM38A, TOR1AIP1 (LAP1), and EMD (emerin) in genome organization

• Many NETs misregulated in myotonic dystrophy are also mutated in Emery-Dreifuss muscular dystrophy, suggesting molecular similarities between different muscular dystrophies

• PLPP7 has been linked to the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex via SAMP1, suggesting a role in nuclear-cytoskeletal coupling

Methodological approaches to study these relationships include:

• Co-immunoprecipitation using PLPP7 antibodies to identify protein interaction partners

• Proximity ligation assays to confirm in situ protein-protein interactions

• Genome organization studies using techniques like Hi-C or ChIP-seq

How can single-cell approaches advance our understanding of PLPP7 function in heterogeneous tissues?

Advanced single-cell technologies offer new opportunities to understand PLPP7 function in complex tissues:

• Single-cell RNA sequencing can reveal cell-type-specific expression patterns of PLPP7

• Combining single-cell transcriptomics with PLPP7 antibody-based immunofluorescence can map protein expression at cellular resolution

• Techniques like CellTag (a lentiviral, combinatorial cell barcoding technology) can enable clonal tracing in heterogeneous samples

• Integrated multi-omics approaches that combine transcriptomics with proteomics can provide a comprehensive view of PLPP7's role in different cell populations

Research indicates that clonal dynamics and lineage tracing approaches are particularly valuable for understanding cellular heterogeneity in complex diseases .